Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Hogan, AB"'
Autor:
Hogan, AB, Winskill, P, Watson, OJ, Walker, PGT, Whittaker, C, Baguelin, M, Brazeau, NF, Charles, GD, Gaythorpe, KAM, Hamlet, A, Knock, E, Laydon, DJ, Lees, JA, Løchen, A, Verity, R, Whittles, LK, Muhib, F, Hauck, K, Ferguson, NM, Ghani, AC
The worldwide endeavour to develop safe and effective COVID-19 vaccines has been extraordinary, and vaccination is now underway in many countries. However, the doses available in 2021 are likely to be limited. We extended a mathematical model of SARS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::76e9734dcb3a27b9753e2ff2cf375656
http://hdl.handle.net/10044/1/87254
http://hdl.handle.net/10044/1/87254
Background The RTS,S/AS01 malaria vaccine is currently being piloted in three African countries. We sought to identify whether vaccination could reach additional children who are at risk from malaria but do not currently have access to, or use, core
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::0edefe4eceb1a7d5374d669a2f608ecb
http://hdl.handle.net/10044/1/83678
http://hdl.handle.net/10044/1/83678
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lambach P; Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Silal S; Modelling and Simulation Hub, Africa, University of Cape Town, Cape Town, South Africa; Centre for Global Health, Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom., Sbarra AN; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States. Electronic address: asbarra1@jhu.edu., Koh M; Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Aggarwal R; Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India., Farooqui HH; College of Medicine, QU Health, Qatar University, Qatar., Flasche S; Centre for Global Health, Charite, Berlin, Germany., Hogan AB; School of Population Health, University of New South Wales, Sydney, Australia., Kim SY; Seoul National University, Seoul, South Korea., Leung K; School of Public Health, The University of Hong Kong, Hong Kong, SAR, China., Moss WJ; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States., Munywoki PK; Kenya Medical Research Institute, Centre for Global Health Research, Nairobi, Kenya., Portnoy A; Department of Global Health, Boston University School of Public Health, Boston, United States; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, United States., Sheel M; School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Sydney Infectious Diseases Institute, Faculty of Medicine and Health, University of Sydney, Sydney, Australia., Wang XY; Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
Publikováno v:
Vaccine [Vaccine] 2024 Nov 12; Vol. 43 (Pt 2), pp. 126519. Date of Electronic Publication: 2024 Nov 12.
Autor:
Barnsley G; MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, UK; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK., Olivera Mesa D; MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, UK., Hogan AB; School of Population Health, University of New South Wales, Sydney, NSW, Australia., Winskill P; MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, UK., Torkelson AA; Linksbridge SPC, Seattle, WA, USA., Walker DG; Management Sciences for Health, Boston, MA, USA., Ghani AC; MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, UK., Watson OJ; MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, UK. Electronic address: o.watson15@imperial.ac.uk.
Publikováno v:
The Lancet. Global health [Lancet Glob Health] 2024 Nov; Vol. 12 (11), pp. e1764-e1774.
Autor:
Nazareno AL; School of Population Health, Faculty of Medicine and Health, UNSW Sydney, New South Wales, Australia; Institute of Mathematical Sciences, College of Arts and Sciences, University of the Philippines Los Baños, Laguna, Philippines. Electronic address: a.nazareno@unsw.edu.au., Newall AT; School of Population Health, Faculty of Medicine and Health, UNSW Sydney, New South Wales, Australia., Muscatello DJ; School of Population Health, Faculty of Medicine and Health, UNSW Sydney, New South Wales, Australia., Hogan AB; School of Population Health, Faculty of Medicine and Health, UNSW Sydney, New South Wales, Australia., Wood JG; School of Population Health, Faculty of Medicine and Health, UNSW Sydney, New South Wales, Australia.
Publikováno v:
Vaccine [Vaccine] 2024 Oct 17; Vol. 42 (26), pp. 126418. Date of Electronic Publication: 2024 Oct 17.
Autor:
Lambach P; Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Silal S; Modelling and Simulation Hub, Africa, University of Cape Town, Cape Town, South Africa; Centre for Global Health, Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom., Sbarra AN; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States. Electronic address: asbarra1@jhu.edu., Koh M; Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Aggarwal R; Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India., Farooqui HH; College of Medicine, QU Health, Qatar University, Qatar., Flasche S; Centre for Global Health, Charite, Berlin, Germany., Hogan AB; School of Population Health, University of New South Wales, Sydney, Australia., Kim SY; Seoul National University, Seoul, South Korea., Leung K; School of Public Health, The University of Hong Kong, Hong Kong SAR, China., Moss WJ; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States., Munywoki PK; Kenya Medical Research Institute, Centre for Global Health Research, Nairobi, Kenya., Portnoy A; Department of Global Health, Boston University School of Public Health, Boston, United States; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, United States., Sheel M; School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, Australia., Wang XY; Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
Publikováno v:
Vaccine [Vaccine] 2024 Oct 03; Vol. 42 (23), pp. 126102. Date of Electronic Publication: 2024 Jul 11.
Autor:
Lambach P; Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Silal S; Modelling and Simulation Hub, Africa, University of Cape Town, Cape Town, South Africa; Centre for Global Health, Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom., Sbarra AN; Johns Hopkins Bloomberg School of Public Health, Baltimore, United States. Electronic address: asbarra1@jhu.edu., Crowcroft NS; Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Frey K; Institute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle, United States., Ferrari M; Pennsylvania State University, State College, United States., Vynnycky E; UKHSA, London, United Kingdom; London School of Hygiene & Tropical Medicine, London, United Kingdom., Metcalf CJE; Department of Ecology and Evolutionary Biology, Princeton University, Princeton, United States., Winter AK; Department of Epidemiology and Biostatistics & Center for the Ecology of Infectious Diseases, University of Georgia, Athens, United States., Zimmerman L; Centers for Disease Control and Prevention, Atlanta, United States., Koh M; Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Sheel M; School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, Australia; Sydney Infectious Diseases Institute, Faculty of Medicine and Health, University of Sydney, Sydney, Australia., Kim SY; Seoul National University, Seoul, South Korea., Munywoki PK; Kenya Medical Research Institute, Centre for Global Health Research, Nairobi, Kenya., Portnoy A; Department of Global Health, Boston University School of Public Health, Boston, United States; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, United States., Aggarwal R; Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India., Farooqui HH; College of Medicine, QU Health, Qatar University., Flasche S; Centre for Global Health, Charite, Berlin, Germany., Hogan AB; School of Population Health, University of New South Wales, Sydney, Australia., Leung K; School of Public Health, The University of Hong Kong, Hong Kong SAR, China., Moss WJ; Johns Hopkins Bloomberg School of Public Health, Baltimore, United States., Wang XY; Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
Publikováno v:
Vaccine [Vaccine] 2024 Sep 13; Vol. 42 (26), pp. 126307. Date of Electronic Publication: 2024 Sep 13.
Autor:
Watson OJ; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London W12 0BZ, UK. Electronic address: o.watson15@imperial.ac.uk., Hogan AB; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London W12 0BZ, UK; School of Population Health, University of New South Wales, Sydney, NSW, Australia.
Publikováno v:
The Lancet. Respiratory medicine [Lancet Respir Med] 2024 Sep; Vol. 12 (9), pp. 663-664. Date of Electronic Publication: 2024 Aug 07.
Autor:
Lambach P; Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Silal S; Modelling and Simulation Hub, Africa, University of Cape Town, Cape Town, South Africa; Centre for Global Health, Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom., Sbarra AN; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States. Electronic address: asbarra1@jhu.edu., Koh M; Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Aggarwal R; Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India., Farooqui HH; College of Medicine, QU Health, Qatar University, Qatar., Flasche S; Centre for Global Health, Charite, Berlin, Germany., Hogan AB; School of Population Health, University of New South Wales, Sydney, Australia., Kim SY; Seoul National University, Seoul, South Korea., Leung K; School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region., Moss WJ; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States., Munywoki PK; Kenya Medical Research Institute, Centre for Global Health Research, Nairobi, Kenya., Portnoy A; Department of Global Health, Boston University School of Public Health, Boston, United States; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, United States., Sheel M; School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, Australia., Wang XY; Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
Publikováno v:
Vaccine [Vaccine] 2024 May 31; Vol. 42 (15), pp. 3379-3383. Date of Electronic Publication: 2024 May 03.